Celldex Therapeutics, Inc. — Director's Dealing 2015

Jun 11, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Celldex Therapeutics, Inc. (CLDX)
CIK: 0000744218
Period of Report: 2015-06-10

Reporting Person: KELER TIBOR (Executive VP & CSO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-06-10	Incentive Stock Option	$25.41	A	116500	Acquired	2025-06-10	Common Stock (116500)	Direct

Footnotes

F1: 25% vest on June 10, 2016 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters.